CNCT19 cell injection
HY001021
Phase 1 mab active
Quick answer
CNCT19 cell injection for Neurological Autoimmune Diseases is a Phase 1 program (mab) at Juventas Cell Therapy with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Juventas Cell Therapy
- Indication
- Neurological Autoimmune Diseases
- Phase
- Phase 1
- Modality
- mab
- Status
- active